PepGen (PEPG) Interest & Investment Income (2022 - 2026)
PepGen (PEPG) posted Interest & Investment Income of $1.2 million for Q1 2026, down 11.91% sequentially from $1.4 million in Q4 2025, and up 11.41% YoY from $1.1 million in Q1 2025.
Analysis
PepGen (PEPG) Interest & Investment Income (2022 - 2026) Analysis & Trends
PepGen has reported Interest & Investment Income for 5 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Interest & Investment Income rose 11.41% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (down 36.51% YoY) and the FY2025 annual result came in at $4.0 million, down 43.76% from the prior year.
- Interest & Investment Income fell to $1.2 million in Q1 2026 per PEPG's latest filing, from $1.4 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $2.1 million in Q2 2024 and troughed at $9000.0 in Q1 2022.
- A 5-year average of $1.3 million and a median of $1.4 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income soared 19811.11% in 2023, then slumped 65.28% in 2025.
- Over 5 years, Interest & Investment Income stood at $1.6 million in 2022, then retreated by 15.4% to $1.3 million in 2023, then rose by 8.47% to $1.5 million in 2024, then retreated by 2.81% to $1.4 million in 2025, then decreased by 11.91% to $1.2 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $1.2 million, $1.4 million, and $634000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | 1.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | 842,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Sep 30, 2022 | 943,000.00 |
| Jun 30, 2022 | 250,000.00 |
| Mar 31, 2022 | 9,000.00 |